HCMG
GILD icon

Howard Capital Management Group’s Gilead Sciences GILD Stock Holding History

Howard Capital Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-835
Closed -$92.6K – 143
2025
Q2 		$92.6K Hold
835
– – 0.01% 133
2025
Q1 		$93.6K Buy
+835
New +$86.2K 0.01% 133
2023
Q4 		– Sell
-835
Closed -$62.6K – 115
2023
Q3 		$62.6K Buy
+835
New +$64.2K 0.01% 110

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Howard Capital Management Group's GILD Position: Q3 2025 in Review

Howard Capital Management Group sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 835 shares — an estimated $92.6K sold.

Howard Capital Management Group first reported a position in GILD in Q3 2023 and held it in 3 quarters. The position peaked at $93.6K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Howard Capital Management Group reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Howard Capital Management Group sold 835 Gilead Sciences shares in Q3 2025, an estimated $92.6K.
  • Howard Capital Management Group first reported a position in Gilead Sciences in Q3 2023 and held it in 3 quarters.
  • Howard Capital Management Group's Gilead Sciences position peaked at $93.6K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Howard Capital Management Group's 13F filing for Q3 2025, filed 16 Oct 2025.